Coffee after a large meal, a small fruit at the end, and water during it? Dr. Maya Rosman puts things in order—what is ...

Staying on top of your health isn’t just about hitting the gym, eating well, or getting the necessary vaccines. It also means ...

The US FDA has approved the drug Mitapivat, marketed as Aqvesme, as the very first oral therapy for anemia in adults with ...

The US FDA has greenlit Mitapivat, the first oral treatment for anaemia in adults with thalassemia, marking a significant advancement in thalassemia care.

HealthDay News — Iron deficiency without anemia is a common feature of moderate-to-severe atopic dermatitis (AD), according to a study published online Nov. 27 in Nutrients.

CT scan of chest, abdomen, and pelvis shows high-disease burden, including multiple mediastinal and hilar nodes, deposits in ...

A recent study revealed that iron deficiency without anemia is common among adults with moderate-to-severe atopic dermatitis ...

The FDA has expanded the approval of Jascayd (nerandomilast), an oral phosphodiesterase 4 (PDE4) inhibitor, to include treatment of progressive pulmonary fibrosis in adults.

Interventional cardiologists say some cases that coders flag and submit to the NCDR aren’t in fact problematic.

Iron deficiency without anemia is widespread among adult patients with moderate to severe atopic dermatitis. Polish researchers came to this conclusion based on the results of a clinical analysis.

Possible Reasons, and The Best Labs for Fatigue Key Takeaways: Fatigue describes more than just feeling sleepy — it’s a ...

FDA expands Accrufer approval to treat iron deficiency in pediatric patients aged 10 years and older based on phase 3 FORTIS trial outcomes.